A phase II study of trifluridine/tipiracil, irinotecan, and bevacizumab in pretreated metastatic colorectal cancer (TABAsCO). Background: Immune checkpoint inhibitors ...

Peritoneal carcinomatosis from colorectal cancer: Not a lost cause. Background: Y-90 radioembolization has shown promise in the treatment of unresectable metastatic colorectal cancer (mCRC) and ...

Hackensack Meridian Health Bayshore Medical Center now offers Y-90 radioembolization, an advanced and minimally invasive method to treat liver tumors without surgery. This procedure is used to treat ...

ABK Biomedical, Inc. announced the first patient treated in ABK’s First-in-Human study with Eye90 microspheres™, a Y90 radioembolization device for the treatment of liver cancers. This study is being ...

Children’s Healthcare of Atlanta is one of the first pediatric centers to offer Y90 Radioembolization treatment to pediatric patients with liver cancer. The system recently completed treatment on its ...

Hackensack Meridian Health Riverview Medical Center is pleased to announce that it now offers Y-90 radioembolization, an innovative and minimally invasive method to treat liver tumors without surgery.

None — Liver Cancer Cancer is classified as being primary (the site of origin) or metastatic (spread from another area of the body). The American Cancer Society estimates that 24,120 new cases of ...

Intrahepatic cholangiocarcinoma (ICC) is a rapidly progressing malignancy; only a minority of the tumours can be resected and the palliative regimens have shown limited success. The aim of this study ...

HALIFAX, NS, Feb. 24, 2026 /CNW/ - ABK Biomedical, Inc., an innovative, medical device company dedicated to the research, development, and commercialization of advanced imageable embolic medical ...